Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemoporfin photodynamic therapy versus pulsed dye laser for port-wine stain
ChiCTR1800014912Phase 4Not yet recruiting
- Sponsor
- Peking University Shenzhen Hospital
- Start
- Sep 2017
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hemoporfin in port-wine stain (2 arms), sponsored by Peking University Shenzhen Hospital. Primary endpoints: PWS perfusion, PWS area and 1 more. Planned start Sep 2017; status: not yet recruiting.
02
Drugs
hemoporfin
03
Conditions
port-wine stain
Beyond the preview
Go deeper on ChiCTR1800014912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014912.